newsfilter
← Latest News
PR Newswire·

Genprex to Participate at BIO Europe Spring 2026

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for...